Literature DB >> 6438848

Immunobiology of strongyloidiasis.

R M Genta.   

Abstract

Strongyloides stercoralis causes a usually silent infection that, under certain conditions of altered host-parasite balance, may become a severe, often fatal, disseminated disease. Patients, as well as experimental animals, develop specific humoral and cellular responses to the tissue-invading stage of the parasite, the filariform larvae. These responses, however, while potentially useful for diagnostic purposes, appear to be of little importance in determining the course of the disease. It is suggested that local intestinal factors may play a central role in the control of autoinfection. Until these questions are resolved and more accurate diagnostic methods are devised, preventive therapy in all patients from endemic areas that must undergo immunosuppressive therapy is advised.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6438848

Source DB:  PubMed          Journal:  Trop Geogr Med        ISSN: 0041-3232


  5 in total

1.  Hyperinfection strongyloidiasis in renal transplant recipients.

Authors:  Mehnaaz S Khuroo
Journal:  BMJ Case Rep       Date:  2014-08-22

2.  Disseminated strongyloidiasis: a retrospective study of clinical course and outcome.

Authors:  C S Lam; M K H Tong; K M Chan; Y P Siu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-01       Impact factor: 3.267

3.  Intestinal immune cells in Strongyloides stercoralis infection.

Authors:  A Trajman; T T MacDonald; C C Elia
Journal:  J Clin Pathol       Date:  1997-12       Impact factor: 3.411

4.  Demonstration and partial characterization of parasite-specific immunoglobulin A responses in human strongyloidiasis.

Authors:  R M Genta; D F Frei; M J Linke
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948

Review 5.  A fatal case of systemic strongyloidiasis and review of the literature.

Authors:  L H Hagelskjaer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-12       Impact factor: 3.267

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.